Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2020 Nov 20;23(1):238. doi: 10.1038/s41436-020-01041-5

Correction: Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease

Daniel G Bichet 1, Johannes M Aerts 2, Christiane Auray-Blais 3, Hiroki Maruyama 4, Atul B Mehta 5, Nina Skuban 6, Eva Krusinska 6, Raphael Schiffmann 7,
PMCID: PMC7790740  PMID: 33219325

Correction to: Genetics in Medicine 2020; 10.1038/s41436-020-00968-z; published online 30 September 2020

This Article was originally published under Nature Research’s License to Publish, but has now been made available under a [CC BY-NC-ND 4.0] license. The PDF and HTML versions of the Article have been modified accordingly.

Footnotes

Author working as a consultant under the contract of Pharmaland Consulting Group.


Articles from Genetics in Medicine are provided here courtesy of Nature Publishing Group

RESOURCES